Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc.
Cardio Diagnostics Holdings stock last closed at $0.37, down 5.13% from the previous day, and has decreased 50.6% in one year. It has overperformed other stocks in the Biotechnology industry by 0.27 percentage points. Cardio Diagnostics Holdings stock is currently +94.74% from its 52-week low of $0.19, and -79.1% from its 52-week high of $1.77.
At the moment, there are 52.15M CDIO shares outstanding. The market value of CDIO is $19.29M. In the past 24 hours, 248,474 CDIO shares were traded.
How to Buy Cardio Diagnostics Holdings Stock
Wondering how to invest in Cardio Diagnostics Holdings stock? Here's how.
Decide where to buy Cardio Diagnostics Holdings stock: You need to pick an online brokerage, but don't worry - we've researched dozens of online brokerages and apps to help you figure out where to buy Cardio Diagnostics Holdings stock.
Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
Deposit money your investment account: Pick your method of payment and add your info.
Evaluate Cardio Diagnostics Holdings stock: The Cardio Diagnostics Holdings ticker symbol is CDIO. Is Cardio Diagnostics Holdings stock a good investment? Should you buy shares of CDIO? How do CDIO's underlying business fundamentals look? Do top analysts think Cardio Diagnostics Holdings is a good buy? Why has CDIO's stock price moved recently? (Hint: Our stock research website can help you decide if CDIO is a good stock to buy).
Execute your CDIO buy order: Decide if you will purchase CDIO shares at the current market price or use a limit order to purchase CDIO stock at a specific price.
Get the latest news on your CDIO position: Create a watchlist to important updates regarding your new investment in Cardio Diagnostics Holdings shares.
Step 1: Decide where to buy Cardio Diagnostics Holdings stock
You need an online brokerage account in order to access the NASDAQ market and buy CDIO stock.
A brokerage account is an investment account that allows you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
Based on our analysis, eToro is the best stock brokerage. eToro gives you:
Invest in stocks with 0% commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
Access to world markets: From Tech to Utilities, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
Social investing: eToro boasts a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by signing up for an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for your brokerage account
Now that you've chosen your brokerage, the next step is to fill out some personal information so you are able to buy CDIO today.
After you have figured out the best place to buy Cardio Diagnostics Holdings stock, it's crucial to research their stock prior to buying, so you truly comprehend the risk and upside.
Cardio Diagnostics Holdings Numbers
CDIO Price
$0.37
1w %
-4.88%
1y %
-50.6%
5y %
N/A
P/E
-1.19x
P/B
2.02x
P/S
370x
PEG
N/A
Revenue
$34.89k
Earnings
-$8.38M
Fore. Rev. Growth
28,561.51%
Fore. Earn. Growth
N/A
Market Cap
$19.29M
Next Earnings
N/A
Next Dividend
N/A
CDIO Fundamentals
WallStreetZen was designed to help average investors perform more in-depth fundamental analysis in minutes instead of hours.
Last year, CDIO revenue was $34.89k. During the last three year, CDIO's revenue has grown by 335.38% per year. This was faster than the Biotechnology industry average of 44.31%.
No, Cardio Diagnostics Holdings doesn't provide an income stream by paying out dividends.
What do other traders have to say about CDIO?
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Execute your CDIO buy order
There are two main order types:
Market order: A market order is an order to buy or sell a stock at the best available price. Market orders are usually fine.
Limit order: A limit order enables you to buy or sell a stock at a specific price (or better). If you want to make sure you're buying or selling at a particular dollar amount limit, place a limit order.
Hit the Open Trade button and your broker will execute your order.
If you need additional help buying stocks on eToro, click the how to video below:
How much does it cost to buy one Cardio Diagnostics Holdings share?
As of Apr 21, 2025, it costs $0.37 to buy one share of Cardio Diagnostics Holdings stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.19, you can buy 0.5 shares of CDIO.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.